Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions

OBJECTIVE: Paracrine signaling in fetal membranes and uterus is hypothesized to play a role in the initiation of labor in women. Numerous fetal membrane signals that stimulate uterine contractions have been described. Recently, by means of the dual-chamber, fetal membrane, uteirne muscle model we sh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 1995-04, Vol.172 (4), p.1216-1223
Hauptverfasser: Collins, Patricia L., Idriss, Edo, Moore, John J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1223
container_issue 4
container_start_page 1216
container_title American journal of obstetrics and gynecology
container_volume 172
creator Collins, Patricia L.
Idriss, Edo
Moore, John J.
description OBJECTIVE: Paracrine signaling in fetal membranes and uterus is hypothesized to play a role in the initiation of labor in women. Numerous fetal membrane signals that stimulate uterine contractions have been described. Recently, by means of the dual-chamber, fetal membrane, uteirne muscle model we showed that fetal membranes inhibit spontaneous uterine contractions. This study was designed to test whether human fetal membranes can also inhibit agonist-induced uterine contractions. STUDY DESIGN: A rat uterine muscle strip was mounte dinto the maternal side of a Plexiglas acrylic plastic chamber, Uterino contractions were recorded for 3 hours after the addition of either 50 nmol/L prostaglandin E 2 or 0.1 nmol/L oxytocin to the maternal side of the chamber. During the first and third hours no fetal membranes were present (basal condition). At the beginning of the second hour fetal membranes were inserted into the chamber so that they divided the chamber into maternal and fetal compartments. The membranes were removed before the beginning of the third hour. The integrated force of uterine contractions during the second hour, when the muscle was exposed to fetal membranes, was compared with the basal condition (first and third hours) by repeated-measure analysis of variance. RESULTS: Fetal membranes reversibly inhibited prostaglandin E 2-induced uterine contractions by 22%. Fetal membranes did not inhibit oxytocin-induced uterine contractions. CONCLUSIONS: Fetal membranes inhibit agonist-induced uterine contractions. The fetal membrane inhibitory system is agonist selective.
doi_str_mv 10.1016/0002-9378(95)91482-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77236458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000293789591482X</els_id><sourcerecordid>77236458</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-4685b513f8c9709fb7e64bd9f886640058b8934d9799672384dd95c43d7205a03</originalsourceid><addsrcrecordid>eNp9kE1rFEEQhhtRkk3MPzAwB5HkMNrfHxdBQhKFgAcN5Nb0dNdoy0xP7O4R8-_tzS579FQU9VTx1oPQG4LfE0zkB4wx7Q1T-sKIS0O4pv3DC7Qh2Kheaqlfos0BOUYnpfzattTQI3SkFJVUmA36dgPVTd0M85BdgtLF9DMOsXaPeSnV_ZhcCjF1w1q7tNRu-ftUFx9TH1NYPYRurZBjgs4vqWbna1xSeY1ejW4qcLavp-j-5vr71ef-7uvtl6tPd71nWtaeSy0GQdiovVHYjIMCyYdgRq2l5BgLPWjDeDDKGKko0zwEIzxnQVEsHGan6N3ubsv6e4VS7RyLh6llhmUttj3JJBe6gXwH-vZUyTDaxxxnl58swXbr0m7N2K0oa4R9dmkf2tr5_v46zBAOS3t5bf52P3fFu2lsAn0sB4wJignhDfu4w6C5-BMh2-IjpGYvZvDVhiX-P8c_7FKQHw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77236458</pqid></control><display><type>article</type><title>Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Collins, Patricia L. ; Idriss, Edo ; Moore, John J.</creator><creatorcontrib>Collins, Patricia L. ; Idriss, Edo ; Moore, John J.</creatorcontrib><description>OBJECTIVE: Paracrine signaling in fetal membranes and uterus is hypothesized to play a role in the initiation of labor in women. Numerous fetal membrane signals that stimulate uterine contractions have been described. Recently, by means of the dual-chamber, fetal membrane, uteirne muscle model we showed that fetal membranes inhibit spontaneous uterine contractions. This study was designed to test whether human fetal membranes can also inhibit agonist-induced uterine contractions. STUDY DESIGN: A rat uterine muscle strip was mounte dinto the maternal side of a Plexiglas acrylic plastic chamber, Uterino contractions were recorded for 3 hours after the addition of either 50 nmol/L prostaglandin E 2 or 0.1 nmol/L oxytocin to the maternal side of the chamber. During the first and third hours no fetal membranes were present (basal condition). At the beginning of the second hour fetal membranes were inserted into the chamber so that they divided the chamber into maternal and fetal compartments. The membranes were removed before the beginning of the third hour. The integrated force of uterine contractions during the second hour, when the muscle was exposed to fetal membranes, was compared with the basal condition (first and third hours) by repeated-measure analysis of variance. RESULTS: Fetal membranes reversibly inhibited prostaglandin E 2-induced uterine contractions by 22%. Fetal membranes did not inhibit oxytocin-induced uterine contractions. CONCLUSIONS: Fetal membranes inhibit agonist-induced uterine contractions. The fetal membrane inhibitory system is agonist selective.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/0002-9378(95)91482-X</identifier><identifier>PMID: 7726259</identifier><identifier>CODEN: AJOGAH</identifier><language>eng</language><publisher>Philadelphia, PA: Mosby, Inc</publisher><subject>Analysis of Variance ; Animals ; Biological and medical sciences ; Dinoprostone - pharmacology ; Extraembryonic Membranes - enzymology ; Extraembryonic Membranes - physiology ; Female ; Fetal membranes ; Genital system. Reproduction ; Humans ; In Vitro Techniques ; L-Lactate Dehydrogenase - metabolism ; Medical sciences ; Muscle, Smooth - drug effects ; Muscle, Smooth - enzymology ; Muscle, Smooth - physiology ; oxytocin ; Oxytocin - pharmacology ; paracrine signaling ; Pharmacology. Drug treatments ; Pregnancy ; prostaglandins ; Rats ; Rats, Wistar ; Uterine Contraction - drug effects ; Uterus - drug effects ; Uterus - enzymology ; Uterus - physiology</subject><ispartof>American journal of obstetrics and gynecology, 1995-04, Vol.172 (4), p.1216-1223</ispartof><rights>1995</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-4685b513f8c9709fb7e64bd9f886640058b8934d9799672384dd95c43d7205a03</citedby><cites>FETCH-LOGICAL-c386t-4685b513f8c9709fb7e64bd9f886640058b8934d9799672384dd95c43d7205a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0002-9378(95)91482-X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3549,23929,23930,25139,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3520114$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7726259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Collins, Patricia L.</creatorcontrib><creatorcontrib>Idriss, Edo</creatorcontrib><creatorcontrib>Moore, John J.</creatorcontrib><title>Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>OBJECTIVE: Paracrine signaling in fetal membranes and uterus is hypothesized to play a role in the initiation of labor in women. Numerous fetal membrane signals that stimulate uterine contractions have been described. Recently, by means of the dual-chamber, fetal membrane, uteirne muscle model we showed that fetal membranes inhibit spontaneous uterine contractions. This study was designed to test whether human fetal membranes can also inhibit agonist-induced uterine contractions. STUDY DESIGN: A rat uterine muscle strip was mounte dinto the maternal side of a Plexiglas acrylic plastic chamber, Uterino contractions were recorded for 3 hours after the addition of either 50 nmol/L prostaglandin E 2 or 0.1 nmol/L oxytocin to the maternal side of the chamber. During the first and third hours no fetal membranes were present (basal condition). At the beginning of the second hour fetal membranes were inserted into the chamber so that they divided the chamber into maternal and fetal compartments. The membranes were removed before the beginning of the third hour. The integrated force of uterine contractions during the second hour, when the muscle was exposed to fetal membranes, was compared with the basal condition (first and third hours) by repeated-measure analysis of variance. RESULTS: Fetal membranes reversibly inhibited prostaglandin E 2-induced uterine contractions by 22%. Fetal membranes did not inhibit oxytocin-induced uterine contractions. CONCLUSIONS: Fetal membranes inhibit agonist-induced uterine contractions. The fetal membrane inhibitory system is agonist selective.</description><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Dinoprostone - pharmacology</subject><subject>Extraembryonic Membranes - enzymology</subject><subject>Extraembryonic Membranes - physiology</subject><subject>Female</subject><subject>Fetal membranes</subject><subject>Genital system. Reproduction</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>L-Lactate Dehydrogenase - metabolism</subject><subject>Medical sciences</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - enzymology</subject><subject>Muscle, Smooth - physiology</subject><subject>oxytocin</subject><subject>Oxytocin - pharmacology</subject><subject>paracrine signaling</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregnancy</subject><subject>prostaglandins</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Uterine Contraction - drug effects</subject><subject>Uterus - drug effects</subject><subject>Uterus - enzymology</subject><subject>Uterus - physiology</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1rFEEQhhtRkk3MPzAwB5HkMNrfHxdBQhKFgAcN5Nb0dNdoy0xP7O4R8-_tzS579FQU9VTx1oPQG4LfE0zkB4wx7Q1T-sKIS0O4pv3DC7Qh2Kheaqlfos0BOUYnpfzattTQI3SkFJVUmA36dgPVTd0M85BdgtLF9DMOsXaPeSnV_ZhcCjF1w1q7tNRu-ftUFx9TH1NYPYRurZBjgs4vqWbna1xSeY1ejW4qcLavp-j-5vr71ef-7uvtl6tPd71nWtaeSy0GQdiovVHYjIMCyYdgRq2l5BgLPWjDeDDKGKko0zwEIzxnQVEsHGan6N3ubsv6e4VS7RyLh6llhmUttj3JJBe6gXwH-vZUyTDaxxxnl58swXbr0m7N2K0oa4R9dmkf2tr5_v46zBAOS3t5bf52P3fFu2lsAn0sB4wJignhDfu4w6C5-BMh2-IjpGYvZvDVhiX-P8c_7FKQHw</recordid><startdate>19950401</startdate><enddate>19950401</enddate><creator>Collins, Patricia L.</creator><creator>Idriss, Edo</creator><creator>Moore, John J.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950401</creationdate><title>Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions</title><author>Collins, Patricia L. ; Idriss, Edo ; Moore, John J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-4685b513f8c9709fb7e64bd9f886640058b8934d9799672384dd95c43d7205a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Dinoprostone - pharmacology</topic><topic>Extraembryonic Membranes - enzymology</topic><topic>Extraembryonic Membranes - physiology</topic><topic>Female</topic><topic>Fetal membranes</topic><topic>Genital system. Reproduction</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>L-Lactate Dehydrogenase - metabolism</topic><topic>Medical sciences</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - enzymology</topic><topic>Muscle, Smooth - physiology</topic><topic>oxytocin</topic><topic>Oxytocin - pharmacology</topic><topic>paracrine signaling</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregnancy</topic><topic>prostaglandins</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Uterine Contraction - drug effects</topic><topic>Uterus - drug effects</topic><topic>Uterus - enzymology</topic><topic>Uterus - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Collins, Patricia L.</creatorcontrib><creatorcontrib>Idriss, Edo</creatorcontrib><creatorcontrib>Moore, John J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Collins, Patricia L.</au><au>Idriss, Edo</au><au>Moore, John J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>1995-04-01</date><risdate>1995</risdate><volume>172</volume><issue>4</issue><spage>1216</spage><epage>1223</epage><pages>1216-1223</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><coden>AJOGAH</coden><abstract>OBJECTIVE: Paracrine signaling in fetal membranes and uterus is hypothesized to play a role in the initiation of labor in women. Numerous fetal membrane signals that stimulate uterine contractions have been described. Recently, by means of the dual-chamber, fetal membrane, uteirne muscle model we showed that fetal membranes inhibit spontaneous uterine contractions. This study was designed to test whether human fetal membranes can also inhibit agonist-induced uterine contractions. STUDY DESIGN: A rat uterine muscle strip was mounte dinto the maternal side of a Plexiglas acrylic plastic chamber, Uterino contractions were recorded for 3 hours after the addition of either 50 nmol/L prostaglandin E 2 or 0.1 nmol/L oxytocin to the maternal side of the chamber. During the first and third hours no fetal membranes were present (basal condition). At the beginning of the second hour fetal membranes were inserted into the chamber so that they divided the chamber into maternal and fetal compartments. The membranes were removed before the beginning of the third hour. The integrated force of uterine contractions during the second hour, when the muscle was exposed to fetal membranes, was compared with the basal condition (first and third hours) by repeated-measure analysis of variance. RESULTS: Fetal membranes reversibly inhibited prostaglandin E 2-induced uterine contractions by 22%. Fetal membranes did not inhibit oxytocin-induced uterine contractions. CONCLUSIONS: Fetal membranes inhibit agonist-induced uterine contractions. The fetal membrane inhibitory system is agonist selective.</abstract><cop>Philadelphia, PA</cop><pub>Mosby, Inc</pub><pmid>7726259</pmid><doi>10.1016/0002-9378(95)91482-X</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 1995-04, Vol.172 (4), p.1216-1223
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_77236458
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Analysis of Variance
Animals
Biological and medical sciences
Dinoprostone - pharmacology
Extraembryonic Membranes - enzymology
Extraembryonic Membranes - physiology
Female
Fetal membranes
Genital system. Reproduction
Humans
In Vitro Techniques
L-Lactate Dehydrogenase - metabolism
Medical sciences
Muscle, Smooth - drug effects
Muscle, Smooth - enzymology
Muscle, Smooth - physiology
oxytocin
Oxytocin - pharmacology
paracrine signaling
Pharmacology. Drug treatments
Pregnancy
prostaglandins
Rats
Rats, Wistar
Uterine Contraction - drug effects
Uterus - drug effects
Uterus - enzymology
Uterus - physiology
title Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T03%3A18%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fetal%20membranes%20inhibit%20prostaglandin%20but%20not%20oxytocin-induced%20uterine%20contractions&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Collins,%20Patricia%20L.&rft.date=1995-04-01&rft.volume=172&rft.issue=4&rft.spage=1216&rft.epage=1223&rft.pages=1216-1223&rft.issn=0002-9378&rft.eissn=1097-6868&rft.coden=AJOGAH&rft_id=info:doi/10.1016/0002-9378(95)91482-X&rft_dat=%3Cproquest_cross%3E77236458%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77236458&rft_id=info:pmid/7726259&rft_els_id=000293789591482X&rfr_iscdi=true